Want to see GB:MYX full AI Analyst Report?
Top Page
MyCelx Technologies
(LSE:MYX)
Select Model
Select Model
Rating:47Neutral
Price Target:
50.00 p
▲(85.19% Upside)
Action:Reiterated
Date:07/01/26
The score is held back primarily by persistent negative operating and free cash flow despite a notable 2025 revenue and profitability rebound. Technically, the stock shows mixed signals (weak vs the 20-day but above longer-term averages). Valuation is a further drag due to the high P/E and no dividend yield provided.
Positive Factors
2025 Revenue and Profitability Rebound
The sharp 2025 revenue increase and return to positive EBIT, EBITDA, and net income indicate materially improved operating performance. If the rebound persists, greater scale could support stronger market execution and provide a more durable earnings base than the company had in prior years.
Negative Factors
Persistent Negative Cash Generation
Negative operating and free cash flow show that the 2025 accounting profit has not yet translated into cash generation. Continued cash burn could restrict investment capacity and increase funding pressure if losses return or working-capital requirements rise.
Read all positive and negative factors
Positive Factors
Negative Factors
2025 Revenue and Profitability Rebound
The sharp 2025 revenue increase and return to positive EBIT, EBITDA, and net income indicate materially improved operating performance. If the rebound persists, greater scale could support stronger market execution and provide a more durable earnings base than the company had in prior years.
Read all positive factors
MyCelx Technologies (MYX) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£12.30M
Dividend YieldN/A
Average Volume (3M)38.52K
Price to Earnings (P/E)73.0
Beta (1Y)0.33
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees18
SectorIndustrials
Sector Strength72
IndustryIndustrial - Pollution & Treatment Controls
Share Statistics
EPS (TTM)0.01
Shares Outstanding24,363,813
10 Day Avg. Volume5,417
30 Day Avg. Volume38,521
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)1.56
Price to Sales (P/S)0.75
P/FCF Ratio-9.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£11.00M
MyCelx Technologies Business Overview & Revenue Model
Company Description
MYCELX Technologies Corporation is a clean water technology firm that provides water purification systems to a wide array of industries, including the petroleum, power generation, maritime, and heavy manufacturing sectors. The company operates glo...
How the Company Makes Money
MyCelx makes money primarily by selling its filtration and separation solutions and associated consumables and services. Key revenue streams include: (1) Product and system sales: revenue from selling filtration media, vessels/equipment, and integ...
MyCelx Technologies Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
66
Positive
Cash Flow
33
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.74M | 4.90M | 10.91M | 10.03M | 8.48M |
| Gross Profit | 5.62M | 1.34M | 3.89M | 4.44M | 3.27M |
| EBITDA | 1.11M | -2.23M | -2.46M | -2.48M | 19.00K |
| Net Income | 334.00K | -2.72M | -3.71M | -3.99M | -1.43M |
Balance Sheet | |||||
| Total Assets | 8.67M | 10.05M | 10.39M | 13.62M | 15.66M |
| Cash, Cash Equivalents and Short-Term Investments | 812.00K | 1.26M | 383.00K | 1.65M | 3.13M |
| Total Debt | 1.26M | 1.26M | 889.00K | 1.22M | 1.47M |
| Total Liabilities | 3.01M | 4.79M | 3.23M | 2.79M | 3.04M |
| Stockholders Equity | 5.66M | 5.26M | 7.16M | 10.83M | 12.62M |
Cash Flow | |||||
| Free Cash Flow | -898.00K | -2.20M | -1.21M | -3.53M | -3.80M |
| Operating Cash Flow | -863.00K | -2.15M | -1.11M | -2.69M | -3.43M |
| Investing Cash Flow | -35.00K | 2.24M | -181.00K | -842.00K | 5.08M |
| Financing Cash Flow | 450.00K | 792.00K | 0.00 | 2.04M | -2.24M |
MyCelx Technologies Technical Analysis
Neutral
27.00
Price Trends
53.04
Negative
55.13
Negative
46.53
Positive
Market Momentum
-0.36
Negative
49.99
Neutral
73.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MYX, the sentiment is Neutral. The current price of 27 is below the 20-day moving average (MA) of 48.67, below the 50-day MA of 53.04, and below the 200-day MA of 46.53, indicating a neutral trend. The MACD of -0.36 indicates Negative momentum. The RSI at 49.99 is Neutral, neither overbought nor oversold. The STOCH value of 73.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:MYX.
MyCelx Technologies Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £391.79M | 21.40 | 10.96% | 0.81% | 3.47% | 10.35% | |
67 Neutral | £227.14M | -18.72 | -33.79% | 1.60% | -13.43% | ― | |
65 Neutral | £65.67M | 15.54 | 7.54% | ― | 5.28% | 3.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | £52.67M | -15.12 | -5.87% | 2.02% | 20.26% | 89.85% | |
48 Neutral | £753.63M | -20.46 | -14.17% | ― | 23.20% | 18.73% | |
47 Neutral | £12.30M | 72.97 | 7.39% | ― | ― | ― |
* Industrials Sector Average
GB:MYX
MyCelx Technologies
54.00
27.00
100.00%
GB:DIA
Dialight
568.00
342.00
151.33%
GB:FLO
Flowtech Fluidpower
65.00
-3.50
-5.11%
GB:ITM
ITM Power
102.10
39.90
64.15%
GB:PRV
Porvair
856.00
134.57
18.65%
GB:WATR
Water Intelligence
345.00
39.00
12.75%
MyCelx Technologies Corporate Events
Business Operations and StrategyFinancial Disclosures
MyCelx boosts H1 revenue and secures key produced water contracts
Positive
Sep 10, 2026
MyCelx Technologies reported a 26% rise in first-half 2026 revenue to $2.1 million, driven by paid trials, equipment leases and recurring media sales that lifted gross margin to 57%, while losses narrowed versus the prior year. Operationally, the ...
Shareholder Meetings
MYCELX Sends 2026 Annual Meeting Notice to Shareholders
Neutral
Aug 3, 2026
MYCELX Technologies Corporation has mailed the Notice of its 2026 Annual Meeting to shareholders, following the June distribution of its 2025 Annual Report. The notice is available on the company’s website and at its Norcross, Georgia headqu...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
MYCELX Targets Strong H2 as Permian and Offshore Water Projects Build Momentum
Positive
Jul 30, 2026
MYCELX reported unaudited H1 2026 revenue of about $2.1 million, up from $1.7 million a year earlier, driven by paid trials, leases and recurring media sales. Management expects a significantly stronger second half, underpinned by a $3.9 million R...
Business Operations and StrategyExecutive/Board Changes
MyCelx Chair to Step Down as Company Names Interim Successor
Neutral
Jun 30, 2026
MyCelx Technologies announced that Chair and Director Gareth Kaminski-Cook will step down from the board effective 31 July 2026 as he reduces his work commitments. His departure comes as the company reports growing momentum in executing its strate...
Financial DisclosuresShareholder Meetings
MYCELX Issues 2025 Annual Report and Sets Date for 2026 Annual Meeting
Neutral
Jun 16, 2026
MYCELX Technologies Corporation has mailed its 2025 Annual Report to shareholders following the release of its final results for the year ended 31 December 2025. The report is also available on the company’s website and can be obtained free ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.